{"name":"Hospira, now a wholly owned subsidiary of Pfizer","slug":"hospira-now-a-wholly-owned-subsidiary-of-pfizer","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Epoetin biosimilar","genericName":"Epoetin biosimilar","slug":"epoetin-biosimilar","indication":"Anemia associated with chronic kidney disease","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"DA-9501","genericName":"DA-9501","slug":"da-9501","indication":"Chronic liver disease / Hepatic fibrosis","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Dexmedetomidine, midazolam; fentanyl","genericName":"Dexmedetomidine, midazolam; fentanyl","slug":"dexmedetomidine-midazolam-fentanyl","indication":"Sedation in intensive care unit (ICU) patients","status":"phase_2"}]}],"pipeline":[{"name":"Epoetin biosimilar","genericName":"Epoetin biosimilar","slug":"epoetin-biosimilar","phase":"phase_2","mechanism":"Stimulates erythropoiesis by binding to the erythropoietin receptor","indications":["Anemia associated with chronic kidney disease","Anemia associated with chemotherapy"],"catalyst":""},{"name":"DA-9501","genericName":"DA-9501","slug":"da-9501","phase":"phase_3","mechanism":"DA-9501 is a standardized herbal extract that modulates inflammatory and immune pathways to improve hepatic function and reduce liver injury.","indications":["Chronic liver disease / Hepatic fibrosis","Drug-induced liver injury"],"catalyst":""},{"name":"Dexmedetomidine, midazolam; fentanyl","genericName":"Dexmedetomidine, midazolam; fentanyl","slug":"dexmedetomidine-midazolam-fentanyl","phase":"phase_2","mechanism":"Alpha-2 adrenergic receptor agonist","indications":["Sedation in intensive care unit (ICU) patients","Anesthesia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQQUMyZ040Y00yOVlLcmM0bUZla3hEbXZaWUdQUkpxMk95NUppZmdIX2Z5VTFCdWgyVEFXRDF3bUdfeXpneWl1MTdkOTNPc3ZIVXZlVFFOMS1jSmNtLUFuRUllRUlRMGt4WlJfNWc1Y1Z0NzVXeThhSXVWZ3FIanZvdi1URXFvbndwVzk3RHR3?oc=5","date":"2020-06-22","type":"pipeline","source":"Business Chief","summary":"Pfizer's most expensive acquisitions - Business Chief","headline":"Pfizer's most expensive acquisitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPc0NmNU9rclplZEpYdm9KTk96VUFxQWVwWVFnbWVCQ0VIMTV1SGo3ZVZmLW42aUNFVjJZaDYwek10VjdkNk8zMzlXTWxTRXJaMTdTTmlobkRUTURORzBfVlRvZi1kM3QzT0FmQ3QxV1JlMXc5aEEycFBaRGJHTm1kMHV4VF9NUzhLQUYyTUlJU1NJRUh6WXpGS2hGNHZrWnRZVjBkSmhfT2x4VGFIUHhwNzVIcXpaNmRHSGc?oc=5","date":"2016-04-04","type":"patent","source":"Pharmaceutical Technology","summary":"The Giants: The World's Largest Generic Pharmaceutical Companies - Pharmaceutical Technology","headline":"The Giants: The World's Largest Generic Pharmaceutical Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNSUxXYXdXS3lDM2lEOENqY1M4eXU0LVg5b2hjV1BKUjBUQllXY09MT3pfR0JUYTI0UURqaWpqY0t1Njh4bnJRZkhCSE92X3AteWJjcVlQSEY1anRnTG1GM1AtSlRmNUEyOEg3SmUweVRnVFpQam1mNVZDUDB6T1RYUmo3NHFQYkYtZ29fOWRERkFnYU81eC1yUnhScWhDVW1NN0lCUnVJNlpDblVBYkJ3OThoNF93UjBRaHd3?oc=5","date":"2015-12-20","type":"pipeline","source":"Pharmaceutical Technology","summary":"The biggest pharmaceutical company takeovers in 2015 - Pharmaceutical Technology","headline":"The biggest pharmaceutical company takeovers in 2015","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":2,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}